Chapter 31: Obstructive Pulmonary Diseases: Drugs Flashcards
cause tachycardia (2)
SABA, formoterol
first-line agents that are most effective short-term controller drugs for asthma
inhaled corticosteroids
(SABAs, SAMAs) are used first
SABAs
produce bronchodilation within minutes (2)
SAMA, SABA
olodaterol: class, uses, and forms
inhaled long-acting beta2-adrenergic agonist (LABA)
uses: COPD
forms: MDI
Suggested options for COPD drug treatment: less than 2 exacerbations, no hospitalizations with fewer daily symptoms
SABA or LABA
albuterol: class, uses, and forms
inhaled short-acting beta2-adrenergic agonists (SABA)
uses: asthma, COPD
forms: nebulizer, MDI
cause dizziness (3)
SAMA, olodaterol, montelukast
When LABAs are used to treat COPD, they can be used as ______________ but should not be used for rapid relief of ________
monotherapy, dyspnea
cause fatigue (1)
montelukast
type of inhaler: some need to be shaken before use (read package insert)
metered-dose inhaler (MDI)
montelukast: class, uses, and forms
leukotriene modifier: leukotriene receptor antagonist
uses: asthma
forms: oral
prednisone: class, uses, and forms
corticosteroid
uses: asthma, COPD
forms: oral
first-line treatment for most patients with COPD
bronchodilators
type of inhaler: often 1 inhalation per dose
dry powder inhaler (DPI)
small, hand-held, pressurized devices that deliver a measured dose of drug with each activation
metered-dose inhaler (MDI)
cause GI distress (2)
formoterol, montelukast
contains dry, powdered medication and is breath activated
dry powder inhaler (DPI)
cause hyperglycemia (1)
corticosteroids
ipratropium: class, uses, and forms
short-acting anticholinergic (SAMA)
uses: asthma, COPD
forms: nebulizer, MDI
cause tremors (2)
SABA, formoterol
formoterol: class, uses, and forms
inhaled long-acting beta2-adrenergic agonist (LABA)
uses: asthma
forms: DPI, nebulizer
When using a nebulizer, the patient must breathe (slowly, quickly) and (shallowly, deeply) through the mouth and hold each inspiration for _________, breathing normally in between.
slowly, deeply, 2-3 seconds
cause nausea (1)
SABA
Suggested options for COPD drug treatment: more than 2 exacerbations, 1 hospitalization with fewer daily symptoms
LAMA
When LABAs are used to treat asthma, they are never used as ______________ but in combination with _______________
monotherapy, inhaled corticosteroids
oral albuterol is _____________ and not used for acute situations
long-acting
type of inhaler: often 2 inhalations per dose
metered-dose inhaler (MDI)
albuterol: use with caution in patients with __________ disorders due to increased BP and HR, CNS stimulation, and increased risk for dysrhythmias
cardiac
type of inhaler: do not shake
dry powder inhaler (DPI)
(some MDIs- read insert)
Suggested options for COPD drug treatment: more than 2 exacerbations, 1 hospitalization with more daily symptoms
LAMA or LABA and LAMA or LABA and ICS
Asthma: In most circumstances, a _____________ drug is used first, followed by a _____________ drug
quick-acting drug, reliever
cause palpitations (1)
SAMA
cause headache (3)
SAMA, SABA, montelukast
use with caution in diabetes, can increase glucose levels
formoterol
albuterol: (MDI, nebulizer) is more effective and delivers drug more quickly to the lungs
MDI
cause dry mouth (1)
SAMA
type of inhaler: slow inspiration
metered-dose inhaler (MDI)
type of inhaler: rapid inspiration
dry powder inhaler (DPI)
type of inhaler: spacer may be used
metered-dose inhaler (MDI)
cause cold symptoms (1)
olodaterol
effects of albuterol last ______ hours
2-5
(SABAs, SAMAs) are used in worse situations
SAMAs
SAMAs are only used for __________ acute asthma attacks
severe
Suggested options for COPD drug treatment: less than 2 exacerbations, no hospitalizations with more daily symptoms
LAMA or LABA
type of inhaler: spacer is not used
dry powder inhaler (DPI)
can be used to prevent wheezing and shortness of breath caused by asthma during exercise (not in acute attack)
montelukast
cause fluid retention (1)
corticosteroids